In their 7th year, the CMO Leadership Awards provide Life Science Leader readers with accurate and reliable customer feedback to assist them in choosing a reputable partner for their development and manufacturing needs. Survey participants were recruited from Pharma and Biopharma companies of all sizes and screened for decision-making influence related to working with contract manufacturing suppliers. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with contract manufacturers and clear experiential data.
Peter Coleman, CEO Cobra Biologics commented: “I am delighted that Cobra has been selected for a 2018 CMO Leadership Award. 2017 was an extraordinary year for Cobra, founded on our core principal of providing an exceptional service to our global customers. Each customer has a dedicated project manager responsible for project delivery, supported by an experienced scientific project team who work closely and flexibly with the customer to meet their challenging requirements.”